Search hospitals > Louisiana > New Orleans
University Medical Center New Orleans
Claim this profileNew Orleans, Louisiana 70112
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
255 reported clinical trials
30 medical researchers
Summary
University Medical Center New Orleans is a medical facility located in New Orleans, Louisiana. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. University Medical Center New Orleans is involved with conducting 255 clinical trials across 464 conditions. There are 30 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Scott E. DelacroixLSU Healthcare Network / Metairie Multi-Specialty Clinic5 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Prostate Cancer
28 reported clinical trials
63 drugs studied
Brian C. BoulmayUniversity Medical Center New Orleans6 years of reported clinical research
Studies Lung Cancer
Studies Parotid Gland Cancer
19 reported clinical trials
31 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Parotid Gland Cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Agustin Garcia, M.D.University Medical Center New Orleans8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Clinical Trials running at University Medical Center New Orleans
Breast Cancer
Ovarian Cancer
Lung Cancer
Parotid Gland Cancer
Breast cancer
Cancer
Squamous Cell Carcinoma
Skin Cancer
Liver Cancer
Endometrial Cancer
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University Medical Center New Orleans?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.